Jianbo Zhou
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dual targeting of ferroptosis and immune evasion: STAT3 inhibition as a one-two punch for breast cancer immunotherapy.
Journal: Journal of translational internal medicine
Published: August 27, 2026
Epigenetics in lung cancer precision medicine: from bench to bedside-a narrative review.
Journal: Translational lung cancer research
Published: March 19, 2026
Co-targeting ferroptosis and immune evasion through small molecules in breast cancer.
Journal: Journal of translational internal medicine
Published: December 24, 2025
Isocucurbitacin B targets STAT3 to induce ferroptosis and promote anti-PD1 immunotherapy responses in breast cancer.
Journal: International journal of surgery (London, England)
Published: July 28, 2025
Targeting synthetic lethality in colorectal cancer.
Journal: Chinese medical journal
Published: July 27, 2024
Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer.
Journal: Oncology research
Published: August 08, 2023
New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 10, 2023
Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
Journal: Frontiers in immunology
Published: January 27, 2023
The bioactivities of sclareol: A mini review.
Journal: Frontiers in pharmacology
Published: August 08, 2022
Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.
Journal: Frontiers in pharmacology
Published: February 28, 2022
Last Updated: 09/26/2026